Category: General Pharmaceutical Council (GPhC)
FEATURE: Preparing for AI-Enabled Oversight
“World first” AI early warning system for the NHS announced. What are the implications for healthcare professionals and organisations regulated by the CQC?
Read More
GPhC and Pharmacist Support commit to work together for the wellbeing of registrants
GPhC has signed a memorandum of understanding (MoU) with Pharmacist Support which aims to support the wellbeing of the pharmacy professions.
Read More
Updated valproate safety information and educational materials
The MHRA have published a Drug Safety Update “to support healthcare professionals and patients to implement the existing regulatory requirements.”
Read More
No new distance selling pharmacies applications will be approved
New legislation bans new DSP openings amid concerns that current numbers are already sufficient, safeguarding bricks-and-mortar pharmacies.
Read More
FEATURE: Interim Orders in Professional Regulation
Kings View Chambers on Interim orders, their role in fitness to practise investigations and impacts on healthcare professionals’ practice, careers, and personal well-being.
Read More
Government confirms commitment to reforming the regulation of healthcare professionals
The Government have confirmed in a Written Ministerial Statement, its commitment to reforming the regulation of healthcare professionals.
Read More
FEATURE: Does remediation matter in fitness to practise?
Kings View Chambers, looks at the importance of remediation in fitness to practise, what remediation means and how it can impact on the outcome of an investigation or hearing.
Read More
GPhC scraps plans to ‘anonymise’ fitness to practise cases for ethnicity
The General Pharmaceutical Council (GPhC) has discontinued a project in which it anonymised ethnicity data for registrants involved in fitness-to-practise (FtP) cases.
Read More
GPhC joins forces with other regulators over advertising of weight management medicines
GPhC has issued a joint Enforcement Notice making clear that adverts for named prescription-only medicines (POMs) for weight-management are prohibited.
Read More
Industry-wide collaboration needed to improve homecare medicines services says GPhC
A report by the GPhC has found that further work is needed to ensure patients always receive their medicines from homecare services when they need them.
Read More
Pharmaceutical Society of Northern Ireland’s performance deemed “poor” by the PSA
We have published our annual performance review of the Pharmaceutical Society of Northern Ireland (PSNI).
Read More
GPhC sees weight management prescribing fitness to practise investigations
Since the introduction of the new rules, the GPhC has received nearly 50 concerns related to weight management prescriptions.
Read More
Kings View Chambers
Recent Comments